A Double-Blind, Placebo-Controlled Trial of Flexible-Dose Fesoterodine for Overactive Bladder

Dmochowski R1, Peters K M2, Morrow J D3, Guan Z3, Gong J3, Sun F3, Siami P F4, Staskin D R5

Abstract Category

Pharmacology: Clinical

Abstract 715
Read by Title
Scientific Non Discussion Abstract Session 34
1. Vanderbilt University Medical Center, Nashville, TN, USA, 2. William Beaumont Hospital, Royal Oak, MI, USA, 3. Pfizer Inc, New York, NY, USA, 4. Deaconess Clinic, Evansville, IN, USA, 5. Weill-Cornell Medical College, New York, NY
Links

Abstract